ARTICLE | Management Tracks
Schoenfeld becomes Mark Foundation CEO
Plus new CDO at iosBio, and updates from Cerebral, Helsinn, CureDuchenne and more
May 20, 2022 1:38 AM UTC
The Mark Foundation for Cancer Research named Ryan Schoenfeld as CEO. Schoenfeld joined the Foundation in 2018 and was named CSO in February 2021 and interim CEO the following August. Previously, he built and led a team of data scientists at Janssen Pharmaceuticals, and prior to that, he led medicinal chemistry and chemical biology teams at Roche (SIX:ROG; OTCQX:RHHBY).
Oral vaccine company iosBio Pharma Ltd. hired Craig Laferrière as chief development officer. Laferrière joins iosBio from CANVAX, an international vaccine consulting business, where among other projects he optimized the manufacture of a Haemophilus influenzae type b conjugate vaccine now licensed in Indonesia. ...